Use of stem cells for adults receiving related donor kidney transplants ... EurekAlert (press release) "Antibody-based induction therapy plus calcineurin inhibitors (CNIs) reduce acute rejection rates in kidney recipients; however, opportunistic infections and toxic CNI effects remain challenging. Reportedly, mesenchymal stem cells (MSCs) have ... Collaborative Study from the Diabetes Research Institute Federation and The ... |
